By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ventaira Pharmaceuticals, Inc. (Formerly BattellePharma) 

1801 Watermark Drive, Suite 100

Columbus  Ohio  43215-1037  U.S.A.
Phone: 614-340-2325 Fax: 614-340-2320



Company News
Ventaira Pharmaceuticals Announces Acquisition of Assets by Battelle 10/30/2007 7:38:28 AM
Ventaira Pharmaceuticals Appoints Scientific Advisory Board 9/17/2007 7:37:22 AM
Ventaira Pharmaceuticals Announces Positive Scintigraphy Data With Next-Generation Pulmonary Drug Delivery Device 5/23/2006 10:20:01 AM
Ventaira Pharmaceuticals Announces Agreement With Nypro Inc. To Manufacture Pulmonary Drug Delivery Device 3/21/2006 12:05:40 PM
Ventaira Pharmaceuticals Announces Appointment Of Phyllis Gardner, M.D. To The Company's Board Of Directors 3/14/2006 11:46:48 AM
Ventaira Pharmaceuticals Announces $13.5 Million Private Equity Financing10/19/2005 5:13:12 PM
Board Of Directors Appoints Leslie J. Williams President And CEO Of Ventaira Pharmaceuticals10/19/2005 5:12:28 PM
Ventaira Pharmaceuticals Appoints John Denny As Vice President Of Product Development10/19/2005 5:11:39 PM
Ventaira Pharmaceuticals Appoints Gregory L. Frank To Board Of Directors10/19/2005 5:11:04 PM
Board Of Directors Appoints Leslie J. Williams Chief Operating Officer Of Ventaira Pharmaceuticals10/19/2005 5:10:10 PM